ClickCease

First Actos Trial set for March

Matthews & Associates and Freese & Goss law firms’ continue to aggressively litigate their Actos cases.  Richard Freese and his associates are busy taking depositions and reviewing thousands of pages of documents to build the strongest possible case against Actos’ maker Takeda Pharmaceuticals.

takeda logoThe firms have also been busy defeating several important motions, positioning our cases for the best possible result.  We have filed numerous, to date, in the Circuit Court of Cook County, Illinois, as well as in the Circuit Court in St. Louis, Missouri.

Additionally, in the last few months Consumer Reports released a statement advising consumers that the risks of using pioglitazone (Actos) far outweigh its benefits.  Consumer Reports pointed to bladder cancer as one of those risks.  These statements, as well as the statements of other consumer advocacy groups, affirm our position in this litigation: that Actos causes bladder cancer and Takeda knew of this risk but failed to warn or disclose this information to the FDA.

As these cases continue to develop, we grow more and more confident in our ability to achieve desirable outcomes for our clients.  The firms’ first case is set for trial March 3, 2014.

Share